Nyström P O, Bax R, Dellinger E P, Dominioni L, Knaus W A, Meakins J L, Ohmann C, Solomkin J S, Wacha H, Wittmann D H
Department of Surgery, University Hospital, Linköping, Sweden.
World J Surg. 1990 Mar-Apr;14(2):148-58. doi: 10.1007/BF01664867.
Analysis of the experience with scientific studies on patients with secondary intraabdominal infection has revealed that problems of interpretation and comparability between studies exist as they relate to variable diagnostic criteria, unmeasured severity of disease, and unclear outcome measures. A consistent system of definitions has been developed to address these deficiencies. Intraabdominal infection is defined as clinical peritonitis requiring both operative and microbiological confirmation for proof of infection. The APACHE II system is proposed for grading the severity of the infection and for stratification of patient risk of mortality. Mortality and time until death, on one hand, and recovery and time until recovery, on the other, are proposed as the main outcome measures, both being independently and positively defined. It is anticipated that this system of minimum rules will produce studies that can be compared, hence, accelerating knowledge and understanding about intraabdominal infection and its best treatment.
对继发性腹腔内感染患者的科学研究经验分析表明,由于研究涉及可变的诊断标准、未测量的疾病严重程度以及不明确的结局指标,存在研究解读和可比性方面的问题。已制定了一套统一的定义系统来解决这些不足。腹腔内感染被定义为需要手术和微生物学确认以证明感染的临床腹膜炎。建议使用急性生理与慢性健康状况评分系统(APACHE II)对感染严重程度进行分级,并对患者的死亡风险进行分层。一方面,死亡率和直至死亡的时间,另一方面,恢复情况和直至恢复的时间,被提议作为主要结局指标,两者均被独立且明确地定义。预计这个最低规则系统将产生可比较的研究,从而加速对腹腔内感染及其最佳治疗方法的认识和理解。